ClinicalTrials.gov
ClinicalTrials.gov Menu

Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01068990
Recruitment Status : Recruiting
First Posted : February 17, 2010
Last Update Posted : January 10, 2018
Sponsor:
Information provided by (Responsible Party):
Sang-Ho Choi, Asan Medical Center

Study Description
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This study is a prospective observation study for lower respiratory tract infections in medical intensive care unit. Microbiologic and clinical characteristics and outcomes of patients with severe pneumonia in medical intensive care unit will be monitored and analyzed.

Condition or disease
Severe Pneumonia

Detailed Description:
All patients admitting medical ICU will be monitored for pneumonia. Both community-acquired (including health-care associated pneumonia) and hospital-acquired pneumonia will be included. Collecting data will include patient demographic characteristics, clinical features, microbiological characteristics including molecular work, and outcome.

Study Design
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Estimated Enrollment : 300 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients
Study Start Date : March 2010
Estimated Primary Completion Date : February 2019
Estimated Study Completion Date : February 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Pneumonia
U.S. FDA Resources

Groups and Cohorts
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Identification of etiology of pneumonia [ Time Frame: 7 day from the time of pneumonia diagnosis ]

Secondary Outcome Measures :
  1. Pneumonia-related death [ Time Frame: 1 month ]

Eligibility Criteria
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients admitting or admitted in medical ICU with pneumonia
Criteria

Inclusion Criteria:

  • Patients admitting medical ICU with pneumonia
  • Medical ICU admitted patients who is developed new pneumonia

Exclusion Criteria:

  • Patients already treated more than 48 hours for pneumonia in transferring hospital and no causative organism is isolated
Contacts and Locations
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01068990


Contacts
Contact: Sang-Ho Choi, MD +82-2-3010-3304 sangho@amc.seoul.kr

Locations
Korea, Republic of
Asan Medical Center Recruiting
Seoul, Korea, Republic of, 138-736
Principal Investigator: Sang-Ho Choi, MD         
Sponsors and Collaborators
Asan Medical Center
Investigators
Principal Investigator: Sang-Ho Choi, MD Asan Medical Center
More Information
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Sang-Ho Choi, Doctor, Asan Medical Center
ClinicalTrials.gov Identifier: NCT01068990     History of Changes
Other Study ID Numbers: AICUP
First Posted: February 17, 2010    Key Record Dates
Last Update Posted: January 10, 2018
Last Verified: January 2018

Keywords provided by Sang-Ho Choi, Asan Medical Center:
pneumonia

Additional relevant MeSH terms:
Pneumonia
Critical Illness
Respiratory Tract Infections
Lung Diseases
 Respiratory Tract Diseases
Disease Attributes
Pathologic Processes
Infection